Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| TB TippingPoint BiosciencesCompany profile Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5M | Seed | Biotech | United States | Investors | |
| SO Standing OvationCompany profile Produces high-quality casein from whey permeates using precision fermentation Produces high-quality casein from whey permeates using precision fermentation | €30M | Series B | Biotech, Foodtech | France | Investors | |
| S Develops next-generation cell assay technology for drug discovery | $3.8M | Undisclosed | Biotech | United Kingdom | Investors | |
| O ONCOMATRYXCompany profile Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors | $67M | Series B | Biotech | Spain | Investors | |
| C CentivaxCompany profile Develops vaccines and therapies for universal protection against diverse targets Develops vaccines and therapies for universal protection against diverse targets | $37M | Undisclosed | Biotech | United States | Investors | |
| MS Miraterra SoilCompany profile Develops high-fidelity soil measurement solutions using AI, genomics, and spectroscopy Develops high-fidelity soil measurement solutions using AI, genomics, and spectroscopy | CA$16M | Seed | Biotech, Agritech | Canada | Investors | |
| EB Epoch BiodesignCompany profile Develops enzymatic recycling technology to transform plastic waste into valuable resources Develops enzymatic recycling technology to transform plastic waste into valuable resources | $12M | StrategicUndisclosed | Biotech, Climate tech | United Kingdom | Investors | |
| R RenasensCompany profile Develops textile recycling technology using CO₂ to separate and decolour blended textiles Develops textile recycling technology using CO₂ to separate and decolour blended textiles | €10M | Seed | Biotech, Climate tech | Sweden | Investors | |
| CT Cellbricks TherapeuticsCompany profile Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs | €10M | Seed+Non-DilutiveUndisclosed | Biotech | Germany | Investors | |
| CF Cauldron FermCompany profile Provides continuous hyper-fermentation technology for industrial-scale bio-production Provides continuous hyper-fermentation technology for industrial-scale bio-production | $13.3M | Series A2Series A | Biotech | Australia | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →